SCHEMBL19862803

SCHEMBL19862803

CC(C)(C)c1ccc(-c2cc(-c3ccc(-c4ccccc4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.58
KMT2A Q03164 10/20 0.58
MAPT P10636 8/20 0.58
ALDH1A1 P00352 7/20 0.58
HPGD P15428 7/20 0.58
NTSR1 P30989 1/20 0.58
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KDM4E B2RXH2 5/20 0.50
ADORA1 P30542 2/20 0.50
LMNA P02545 2/20 0.50
ADORA2A P29274 1/20 0.50
GLA P06280 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
CYP2C19 P33261 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.49
TP53 P04637 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KIF11 P52732 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22058528 1.00 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15745467 0.98 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15745465 0.98 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20689999 0.90 KIF11 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20276894 0.90 MEN1 (0.51) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725241 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725301 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725286 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725326 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17725260 0.89 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885MAPT 746/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885MAPT 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.